HomeInsightsStock Comparison

J B Chemicals Pharmaceuticals Ltd vs Piramal Pharma Ltd Stock Comparison

J B Chemicals Pharmaceuticals Ltd vs Piramal Pharma Ltd Stock Comparison

Last Updated on: Jul 18, 2025

Key Highlights

  • The Latest Trading Price of J B Chemicals & Pharmaceuticals Ltd is ₹ 1655 as of 18 Jul 10:53.
  • The P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 14.4 on March 2020 to 38.3 on March 2025 . This represents a CAGR of 17.71% over 6 yearsThe P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 325.4 on March 2025 . This represents a CAGR of -42.71% over 2 years.
  • The Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 3928 crore on March 2020 to ₹ 25253 crore on March 2025 . This represents a CAGR of 36.36% over 6 yearsThe Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 29763 crore on March 2025 . This represents a CAGR of 53.90% over 3 years.
  • The revenue of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 963.96 crore as compare to the Dec '24 revenue of ₹ 971.49 crore. This represent the decline of -0.78% The revenue of Piramal Pharma Ltd for the Mar '25 is ₹ 2812 crore as compare to the Dec '24 revenue of ₹ 2233 crore. This represent the growth of 25.92%.
  • The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 240.92 crore as compare to the Dec '24 ebitda of ₹ 262.51 crore. This represent the decline of -8.22% The ebitda of Piramal Pharma Ltd for the Mar '25 is ₹ 619.24 crore as compare to the Dec '24 ebitda of ₹ 366.92 crore. This represent the growth of 68.77%.
  • The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 142.32 crore to ₹ 145.69 crore over 8 quarters. This represents a CAGR of 1.18% The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ 153.5 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 31.71 % on March 2020 to 36.98 % on March 2025 . This represents a CAGR of 2.60% over 6 yearsThe Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2022 to 2.68 % on March 2025 . This represents a CAGR of -37.94% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
  • The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
  • The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
  • The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
  • Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

J B Chemicals & Pharmaceuticals Ltd News Hub

News

J B Chemicals & Pharmaceuticals to conduct AGM

J B Chemicals & Pharmaceuticals announced that the Annual General Meeting(AGM) of the comp...

Read more

12 Jul 2025 09:53

News

J B Chemicals & Pharmaceuticals Ltd leads losers in 'A' group

Jyoti CNC Automation Ltd, Karnataka Bank Ltd, Narayana Hrudayalaya Ltd and Home First Fina...

Read more

30 Jun 2025 15:00

News

J B Chemicals & Pharmaceuticals receives USFDA approval for Amitriptyline Hydrochloride Tablets

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Adm...

Read more

26 Jun 2025 18:33

News

JB Chemicals receives USFDA approval for Amitriptyline Hydrochloride tablets

The approved dosages'10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg'are indicated for the ...

Read more

25 Jun 2025 12:22

News

J B Chemicals receives USFDA approval for Amitriptyline Hydrochloride Tablets

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Adm...

Read more

24 Jun 2025 18:31

News

J B Chemicals & Pharmaceuticals allots 85,390 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 85,390 equity shares under ESOS. Consequently...

Read more

11 Jun 2025 18:10

Piramal Pharma Ltd News Hub

News

Piramal Pharma to conduct AGM

Piramal Pharma announced that the 5th Annual General Meeting(AGM) of the company will be h...

Read more

14 Jun 2025 14:54

News

Piramal Pharma's Aurora unit completes USFDA inspection

Piramal Pharma announced that the US FDA conducted a general GMP (Good Manufacturing Pract...

Read more

02 Jun 2025 16:21

News

Piramal Pharma's Canada facility gets zero USFDA observation

According to a regulatory filing, the inspection was carried out from 26 May 2025 to 30 Ma...

Read more

02 Jun 2025 11:16

News

Piramal Pharma allots 35 lakh equity shares under ESOP

Piramal Pharma has allotted 35 lakh equity shares under ESOP on 21 May 2025. Consequent to...

Read more

21 May 2025 15:37

News

Board of Piramal Pharma recommends final dividend

Piramal Pharma announced that the Board of Directors of the Company at its meeting held on...

Read more

15 May 2025 10:18

News

Piramal Pharma's Turbhe facility successfully completes USFDA inspection

Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR...

Read more

12 May 2025 12:47

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for J B Chemicals & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of J B Chemicals & Pharmaceuticals Ltd and Piramal Pharma Ltd

Which company has a larger market capitalization, J B Chemicals & Pharmaceuticals Ltd or Piramal Pharma Ltd?

Market cap of J B Chemicals & Pharmaceuticals Ltd is 25,970 Cr while Market cap of Piramal Pharma Ltd is 28,778 Cr

What are the key factors driving the stock performance of J B Chemicals & Pharmaceuticals Ltd and Piramal Pharma Ltd?

The stock performance of J B Chemicals & Pharmaceuticals Ltd and Piramal Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for J B Chemicals & Pharmaceuticals Ltd and Piramal Pharma Ltd?

As of July 18, 2025, the J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹1664.15. On the other hand, Piramal Pharma Ltd stock price is INR ₹216.5.

How do dividend payouts of J B Chemicals & Pharmaceuticals Ltd and Piramal Pharma Ltd compare?

To compare the dividend payouts of J B Chemicals & Pharmaceuticals Ltd and Piramal Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions